<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="wordpress.com" -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"
	xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
	xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
	xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
	>
<url><loc>https://blog.lifesciencenation.com/2026/07/21/hot-investor-mandate-global-pharmaceutical-partner-seeks-novel-therapeutics-and-platform-technologies-through-strategic-collaborations/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-07-21T17:27:14+00:00</news:publication_date><news:title>Hot Investor Mandate: Global Pharmaceutical Partner Seeks Novel Therapeutics and Platform Technologies Through Strategic Collaborations</news:title><news:keywords>technology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligence</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/07/21/hot-investor-mandate-vc-firm-invests-exclusively-in-differentiated-therapeutics-across-all-development-stages-focusing-on-usa-based-companies/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-07-21T17:26:56+00:00</news:publication_date><news:title>Hot Investor Mandate: VC Firm Invests Exclusively in Differentiated Therapeutics Across All Development Stages, Focusing on USA-Based Companies</news:title><news:keywords>technology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligence</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/07/21/hot-investor-mandate-cross-border-vc-firm-backs-life-science-companies-in-high-unmet-need-areas-including-cns-immuno-oncology-and-more/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-07-21T17:26:41+00:00</news:publication_date><news:title>Hot Investor Mandate: Cross-Border VC Firm Backs Life Science Companies in High Unmet Need Areas Including CNS, Immuno-Oncology, and More</news:title><news:keywords>technology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligence</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/07/21/hot-investor-mandate-early-stage-vc-firm-invests-up-to-20m-in-novel-first-in-class-therapeutics-companies-with-us-and-europe-focus/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-07-21T17:26:25+00:00</news:publication_date><news:title>Hot Investor Mandate: Early-Stage VC Firm Invests Up to $20M in Novel, First-In-Class Therapeutics Companies With US and Europe Focus </news:title><news:keywords>technology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligence</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/07/21/cross-border-investor-luncheon-at-resi-boston-2026/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-07-21T14:14:36+00:00</news:publication_date><news:title>Cross-Border Investor Luncheon at RESI Boston 2026</news:title><news:keywords>venture capital, Healthcare, news, science, technology, mental health, startups, marketing, health, travel, AI, business, entrepreneurship, finance, investing, artificial-intelligence, books, digital-marketing, fitness, beauty, education, lifestyle, leadership, inspiration, chatgpt, sustainability, dailyprompt</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/07/21/prepare-for-resi-boston-join-our-pre-conference-webinar-series/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-07-21T14:14:07+00:00</news:publication_date><news:title>Prepare for RESI Boston: Join Our Pre Conference Webinar Series</news:title><news:keywords>venture capital, startup, science, technology, startups, marketing, business, entrepreneurship, finance, writing, education, social-media, leadership</news:keywords></news:news></url><url><loc>https://blog.lifesciencenation.com/2026/07/21/finding-the-right-investors-starts-with-the-right-data/</loc><news:news><news:publication><news:name>Next Phase Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-07-21T14:13:35+00:00</news:publication_date><news:title>Finding the Right Investors Starts with the Right Data </news:title><news:keywords>venture capital, news, science, entrepreneur, technology, startups, marketing, AI, business, entrepreneurship, finance, writing, digital-marketing, education, social-media, dailyprompt</news:keywords></news:news></url></urlset>